Dacarbazine  Medac 1 000 mg inj. sol. (pwdr.) i.v. vial Belgicko - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

dacarbazine medac 1 000 mg inj. sol. (pwdr.) i.v. vial

medac gmbh - dacarbazine citrate 1350 mg - eq. dacarbazine 1000 mg - powder for solution for injection - 1000 mg - dacarbazine citrate 1350 mg - dacarbazine

Dacarbazine  Medac 500 mg inj. sol. (pwdr.) i.v. vial Belgicko - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

dacarbazine medac 500 mg inj. sol. (pwdr.) i.v. vial

medac gmbh - dacarbazine citrate 675 mg - eq. dacarbazine 500 mg - powder for solution for injection - 500 mg - dacarbazine citrate 675 mg - dacarbazine

DACARBAZINE FOR INJECTION BP POWDER FOR SOLUTION Kanada - angličtina - Health Canada

dacarbazine for injection bp powder for solution

pfizer canada ulc - dacarbazine - powder for solution - 600mg - dacarbazine 600mg - antineoplastic agents

DACARBAZINE - DACIN  200 MG Izrael - angličtina - Ministry of Health

dacarbazine - dacin 200 mg

propharm ltd - dacarbazine - powder for solution for inj/inf - dacarbazine 200 mg/vial - other alkylating agents - for the treatment of metastatic malignant melanoma, hodgkin's disease as a second line therapy when used in combination with other agents.

DBL DACARBAZINE 200mg Powder for Injection Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

dbl dacarbazine 200mg powder for injection

pfizer australia pty ltd - dacarbazine, quantity: 200 mg - injection, powder for - excipient ingredients: mannitol; citric acid monohydrate - chemotherapy of metastatic malignant melanoma and various sarcomas. in other cancers, the available evidence shows dacarbazine to be ineffective or less effective than established regimens. note: the use of dacarbazine is restricted to hospitals with an oncology service.

DACARBAZINE injection, powder, for solution Spojené štáty - angličtina - NLM (National Library of Medicine)

dacarbazine injection, powder, for solution

meitheal pharmaceuticals inc. - dacarbazine (unii: 7gr28w0fji) (dacarbazine - unii:7gr28w0fji) - dacarbazine for injection is indicated in the treatment of metastatic malignant melanoma. in addition, dacarbazine for injection is also indicated for hodgkin's disease as a secondary-line therapy when used in combination with other effective agents. dacarbazine for injection is contraindicated in patients who have demonstrated a hypersensitivity to it in the past.

DBL™ Dacarbazine Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

dbl™ dacarbazine

pfizer new zealand limited - dacarbazine 200mg;  ;   - powder for injection - 200 mg - active: dacarbazine 200mg     excipient: citric acid monohydrate mannitol - chemotherapy of metastatic malignant melanoma and various sarcomas. in other cancers, the available evidence shows dacarbazine to be ineffective or less effective than established regimens.